Table 1.
Participant Characteristics at Visit 1 (Top Panel) and Visit 3 (Bottom Panel), Overall and by 10‐Year Predicted ASCVD Risk at Visit 3 (n=1115)
| All Participants (N=1115) | 10‐Year ASCVD Risk at Visit 3 | |||
|---|---|---|---|---|
| <7.5% (N=770) | ≥7.5% (N=345) | P Value | ||
| Characteristics at visit 1 | ||||
| Age, y | 45.2 (9.5) | 41.6 (8.0) | 53.0 (7.6) | <0.001 |
| Age group, y | ||||
| <30 | 70 (6.3) | 69 (9.0) | 1 (0.3) | <0.001 |
| 30 to 39 | 247 (22.2) | 235 (30.5) | 12 (3.5) | |
| 40 to 49 | 454 (40.7) | 348 (45.2) | 106 (30.7) | |
| 50 to 59 | 266 (23.9) | 114 (14.8) | 152 (44.1) | |
| ≥60 | 78 (7.0) | 4 (0.5) | 74 (21.4) | |
| Male sex | 375 (33.6) | 207 (26.9) | 168 (48.7) | <0.001 |
| Less than high school education | 66 (5.9) | 35 (4.5) | 31 (9.0) | 0.006 |
| Current smoker | 105 (9.4) | 57 (7.4) | 48 (13.9) | <0.001 |
| BMI, kg/m2 | 30.8 (7.2) | 31.0 (7.4) | 30.5 (6.8) | 0.32 |
| SBP, mm Hg | 116.7 (10.2) | 115.2 (10.1) | 120.1 (9.6) | <0.001 |
| DBP, mm Hg | 74.1 (7.2) | 73.5 (7.0) | 75.4 (7.4) | <0.001 |
| Total cholesterol, mg/dL | 193.3 (37.7) | 188.9 (36.9) | 203.1 (37.7) | <0.001 |
| HDL cholesterol, mg/dL | 51.6 (13.3) | 52.1 (13.1) | 50.5 (13.6) | 0.06 |
| LDL cholesterol, mg/dL | 124.3 (35.7) | 120.8 (35.2) | 132.2 (35.5) | <0.001 |
| Statin use | 19 (1.8) | 6 (0.8) | 13 (4.1) | <0.001 |
| Characteristics at visit 3 | ||||
| Age, y | 53.2 (9.4) | 49.7 (7.9) | 61.1 (7.5) | <0.001 |
| Age group, y | ||||
| <30 | 7 (0.6) | 7 (0.9) | 0 (0.0) | <0.001 |
| 30 to 39 | 81 (7.3) | 79 (10.3) | 2 (0.6) | |
| 40 to 49 | 316 (28.3) | 293 (38.1) | 23 (6.7) | |
| 50 to 59 | 439 (39.4) | 316 (41.0) | 123 (35.7) | |
| 60 to 69 | 222 (19.9) | 73 (9.5) | 149 (43.2) | |
| ≥70 | 50 (4.5) | 2 (0.3) | 48 (13.9) | |
| Male sex | 375 (33.6) | 207 (26.9) | 168 (48.7) | <0.001 |
| Less than high school education | 64 (5.8) | 32 (4.2) | 32 (9.4) | 0.001 |
| Current smoker | 100 (9.0) | 46 (6.0) | 54 (15.7) | <0.001 |
| BMI, kg/m2 | 32.1 (7.3) | 32.5 (7.8) | 31.1 (6.2) | 0.002 |
| SBP, mm Hg | 121.2 (14.2) | 118.2 (12.7) | 128.0 (14.9) | <0.001 |
| DBP, mm Hg | 76.3 (10.0) | 75.7 (9.4) | 77.7 (10.9) | 0.002 |
| Antihypertensive medication | 355 (31.8) | 182 (23.6) | 173 (50.1) | <0.001 |
| Hypertension | 463 (41.5) | 241 (31.3) | 222 (64.3) | <0.001 |
| Diabetes mellitus | 105 (9.4) | 28 (3.6) | 77 (22.3) | <0.001 |
| Total cholesterol, mg/dL | 199.7 (37.2) | 196.3 (35.7) | 207.4 (39.3) | <0.001 |
| HDL cholesterol, mg/dL | 58.0 (15.3) | 58.6 (15.5) | 56.5 (14.9) | 0.04 |
| LDL cholesterol, mg/dL | 123.9 (34.0) | 120.9 (32.7) | 130.5 (36.0) | <0.001 |
| Statin use | 133 (13.1) | 73 (10.5) | 60 (18.8) | <0.001 |
Numbers in the table are mean (SD) or n (percentage). ASCVD indicates atherosclerotic cardiovascular disease; BMI, body mass index; DBP, diastolic blood pressure; HDL, high‐density lipoprotein; LDL, low‐density lipoprotein; SBP, systolic blood pressure.